To truly understand the intricacies of pathogenic bacteria, we need to combine “pure” and translational research.
New evidence points to the safety – and benefits – of immune checkpoint therapy in HIV-positive cancer patients
A antibody discovery platform emerges to tackle the growing problem of Andes Hantavirus cardiopulmonary syndrome (AHCPS)
A vaccine using mRNA demonstrates potential for broad influenza protection.
Could activated T cells play a major role in driving neurodegeneration in glaucoma?
A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better?
The gates for gene and cell therapies are open, and RNAi technology could be a serious contender
Solutions are needed to teach the immune system to recognize biological drugs as partners, not plunderers.
Gut mucus microbiota could lead to earlier diagnosis, or even prediction, of inflammatory bowel disease.
A unique type of B cell appears to play a role in the development of autoimmune disorders.
Send me the latest from The Translational Scientist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.